Characterizing low fluence thresholds for in vitro photodynamic therapy.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 4361432)

Published in Biomed Opt Express on February 10, 2015

Authors

Brad A Hartl1, Henry Hirschberg2, Laura Marcu1, Simon R Cherry1

Author Affiliations

1: Department of Biomedical Engineering, University of California, Davis, Davis, CA 95616, USA.
2: Beckman Laser Institute and Medical Clinic, University of California, Irvine, Irvine, CA 92697, USA.

Articles cited by this

Photodynamic therapy of cancer: an update. CA Cancer J Clin (2011) 6.08

Optical imaging of Cerenkov light generation from positron-emitting radiotracers. Phys Med Biol (2009) 3.81

Upconverting nanoparticles. Angew Chem Int Ed Engl (2011) 2.93

The physics, biophysics and technology of photodynamic therapy. Phys Med Biol (2008) 2.22

In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers. Nat Med (2012) 2.13

Blue light induces mitochondrial DNA damage and free radical production in epithelial cells. J Biol Chem (2005) 1.80

Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatment. J Nanosci Nanotechnol (2006) 1.54

Photodynamic therapy for treatment of solid tumors--potential and technical challenges. Technol Cancer Res Treat (2008) 1.36

A light blanket for intraoperative photodynamic therapy. Proc SPIE Int Soc Opt Eng (2013) 1.30

Fluence rate as a modulator of PDT mechanisms. Lasers Surg Med (2006) 1.24

Photodynamic therapy with verteporfin: a new treatment in ophthalmology. Semin Ophthalmol (2001) 1.16

Metronomic photodynamic therapy as a new paradigm for photodynamic therapy: rationale and preclinical evaluation of technical feasibility for treating malignant brain tumors. Photochem Photobiol (2004) 1.00

Photodynamic therapy in dermatology: state-of-the-art. Photodermatol Photoimmunol Photomed (2010) 0.99

Photodynamic therapy: Dermatology and ophthalmology as main fields of current applications in clinic. Biomed Mater Eng (2008) 0.97

Photodynamic antifungal chemotherapy. Photochem Photobiol (2012) 0.96

The effects of ultra low fluence rate single and repetitive photodynamic therapy on glioma spheroids. Lasers Surg Med (2009) 0.93

X-ray-induced nanoparticle-based photodynamic therapy of cancer. Nanomedicine (Lond) (2014) 0.92

Photodynamic inactivation of mammalian viruses and bacteriophages. Viruses (2012) 0.91

5-Aminolevulinic acid-induced protoporphyrin-IX accumulation and associated phototoxicity in macrophages and oral cancer cell lines. J Photochem Photobiol B (2007) 0.90

Intracellular chemiluminescence activates targeted photodynamic destruction of leukaemic cells. Br J Cancer (2006) 0.86

Efficacy of 5-aminolevulinic acid-mediated photodynamic therapy using light-emitting diodes in human colon cancer cells. Oncol Rep (2013) 0.84

Two-photon induced luminescence, singlet oxygen generation, cellular uptake and photocytotoxic properties of amphiphilic Ru(II) polypyridyl-porphyrin conjugates as potential bifunctional photodynamic therapeutic agents. Org Biomol Chem (2011) 0.78